Vivos Therapeutics, Inc. (VVOS)
Data as of , from SEC Form 4 filings.
See up to 3 months of VVOS. The 7-day demo opens the 1M and 3M ranges and puts VVOS on your watchlist.
Start 7-day demoLatest VVOS insider trades
Michael C. SkaffOpen-market purchase$500K- Michael C. SkaffOpen-market purchase
About Vivos Therapeutics, Inc. (VVOS)
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
- LITTLETON, CO
- 268
- 2020
- Nasdaq
VVOS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 4 | 424,000 | |
| Other acquisition / disposition | 2 | 171,820 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
VVOS insider transactions (Form 4)
168 Form 4 filings on record, the earliest from Nov 27, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Leonard J. Sokolow - Director | Grant or award | Stock Options (Right to Buy) | 12,000 | $0.00 | - | |
 Gregg C. Johnson - Director | Grant or award | Stock Options (Right to Buy) | 12,000 | $0.00 | - | |
| Ronald Kirk Huntsman - Officer | Other | Preferred Stock | 85,910 | $0.58 | $50K | |
| Ronald Kirk Huntsman - Officer | Other | Warrant (Right to Buy) | 85,910 | $0.58 | $50K | |
| Bradford K. Amman - Officer | Grant or award | Common Stock | 250,000 | $0.41 | $103K | |
| Bradford K. Amman - Officer | Grant or award | Stock Option (Right to Buy) | 150,000 | $0.41 | $61K | |
| Michael C. Skaff | Open-market purchase | Series A Convertible Preferred Stock | 859,166 | $0.58 | $500K | |
| Michael C. Skaff | Open-market purchase | Series A Convertible Preferred Stock | 1,890,164 footnote F3 | $0.58 | $1.10M | |
| Michael C. Skaff | Open-market purchase | Common Stock Purchase Warrant | 2,749,330 | $0.58 | $1.60M | |
| ||||||
| Michael C. Skaff | Open-market purchase | Common Stock | 1,044,777 footnote F1 | $1.34 | $1.40M | |
| Michael C. Skaff | Open-market purchase | Common Stock | 308,848 | $1.34 | $414K | |
| Michael C. Skaff | Open-market purchase | Pre-Funded Warrant | 429,957 | $1.34 | $576K | |
| Michael C. Skaff | Open-market purchase | Series A Common Stock Warrant | 1,783,582 | $1.34 | $2.39M | |
| Michael C. Skaff | Open-market purchase | Series B Common Stock Warrant | 1,783,582 | $1.34 | $2.39M | |
| ||||||
| Ronald Kirk Huntsman - Officer | Grant or award | Stock Option (Right to Buy) | 315,421 | $2.64 | $833K | |
| Bradford K. Amman - Officer | Grant or award | Stock Option (Right to Buy) | 149,533 | $2.64 | $395K | |
VVOS insider trading FAQ
What is the latest insider trade for VVOS?
Vivos Therapeutics, Inc. (VVOS) had 4 insider filings in the last 90 days, with the most recent on 2026-09-19. The full record for VVOS runs to 8 Form 4 filings, the earliest from 2024-11-27. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VVOS stock?
No insider purchases of VVOS were filed in the last 90 days. 8 purchases are on record for this company.
How many insiders are selling VVOS stock?
No insider sales of VVOS were filed in the last 90 days.
Where can I see VVOS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VVOS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
8The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Leonard J. Sokolow view on EDGAR
- - Gregg C. Johnson view on EDGAR
- - Ronald Kirk Huntsman view on EDGAR
- - Bradford K. Amman view on EDGAR
- - Michael C. Skaff view on EDGAR
- - Michael C. Skaff view on EDGAR
- - Ronald Kirk Huntsman view on EDGAR
- - Bradford K. Amman view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where VVOS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VVOS with a 7-day demo
- VVOS on your watchlist
- Every VVOS Form 4 filing on record
- Up to 3 months of VVOS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
